Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

NCT04524884 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: Surufatinib
DRUG: Toripalimab

Sponsor

Fudan University